Search
for
Sort by
Research 631–660 of 1000+
- T Cell Immunodeficiency, Congenital Alopecia, and Nail Dystrophy
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- A comment on the post-finasteride syndrome
- ADRENAL ONCOCYTOMA IN CHILDREN – case report
- Tinea Capitis in an Adolescent Female with Lupus Erythematosus
- The pattern and profile of alopecia areata in Singapore – a study of 219 Asians
- Adrenocortical tumor in 20 months old female
- Epidemiology and burden of alopecia areata: a systematic review
- Minoxidil
- Defining hirsutism in Chinese women: a cross-sectional study
- Pediculosis Capitis
- Vitamin D status in scarring and nonscarring alopecia
- Frictional alopecia of the distal legs: case series and review
- Trichoscopy of the beard: Aid tool for diagnosis of frontal fibrosing alopecia in men
- Relapsing Polychondritis Following Alopecia Areata
- Adrenal myelolipoma: A rare entity
- Heterozygous 21‐hydroxylasedeficiency as a cause of hyperandrogenism
- Safety profile of topical spray minoxidil: An observational study
- Intralesional Platelet-Rich Plasma Injection in Patients with Recalcitrant Alopecia Areata
- 40785 Alopecia Following Solid Organ Transplant: A 10 Year Retrospective Review
- Drugs that affect autonomic functions or the extrapyramidal system
- Reply
- Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Finasteride-its impact on sexual function and prostate cancer
- Response of Sows and Litters to Added Dietary Biotin in Environmentally Regulated Facilities
- Association of Sensorineural Hearing Loss in Patients With Alopecia Areata
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program